Novartis: Alcon lens shows superior performance

(CercleFinance.com) - Alcon's intraocular lenses have showed superior visual performance in head-to-head trial post-cataract surgery, Novartis said on Monday.


Alcon, the eye care unit of Novartis, has unveiled new data showing significantly improved near and intermediate distance vision with its AcrySof IQ PanOptix trifocal intraocular lens compared to Zeiss' comparable product.

Results from the head-to-head study involving 180 patients were presented today at the World Ophthalmology Congress, which is being held in Barcelona.

Copyright (c) 2018 CercleFinance.com. All rights reserved.